A weekly research brief on the bulk drugs, and later the solar and fertiliser inputs, that India's manufacturers import rather than make. Written for analysts and procurement teams who need to know when that dependence moves.
The 41 bulk drugs identified under the PLI scheme, by target segment, and how many in each have an approved project with a named applicant.
Products identified under the PLI scheme by target segment, and how many in each have a named approved applicant: I, 3 of 4; II, 5 of 10; III, 2 of 4; IV, 0 of 23
A Department of Pharmaceuticals notice of 14 May 2025 re-opened applications for eleven unsubscribed or partially subscribed bulk drugs. The window closed on 4 July 2025, and the Department has still not published who, if anyone, took them.
Every input tracked, with its PLI segment, approval status and sources — and an explicit “Not known” wherever a figure has not yet been traced to a primary source.
One email a week, covering what changed and why. Free.